{"story":{"id":914604,"title":"El GLP-1 oral de Lilly se asoció con reducciones significativas en el riesgo de diabetes tipo 2 y enfermedad cardiovascular - Gaceta Médica","permalink":"https://checknews.org/historia.php?id=914604","status":"quiet","category":"business","country":"ES","country_name":"Spain","language":"es","first_seen_at":"2026-10-06T09:10:18-06:00","last_activity_at":"2026-10-06T09:10:18-06:00","source_count":1,"article_count":1,"image":null,"articles":[{"title":"El GLP-1 oral de Lilly se asoció con reducciones significativas en el riesgo de diabetes tipo 2 y enfermedad cardiovascular - Gaceta Médica","publisher":"Gaceta Médica","url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbUZpUWVaUjBwYTM0cWhJVzB0aDFwc25iNHpmRm43MFV6bjBsekpKRGdVaVMzc0p5UkEzMXlyRmRPU1YzNkNtS1pMc2V6YXRIbHNMZlB0Z3BHX2JWM1U2RnNVRXBUU3RHWVFsU1U4VzZNdkVLSXp3Nml2bUhzbHhJTVN1T09rNVF2anl4VXBpRnVrWGNzN0VMQ28yYW1VUy1BOTF0ejdxeVM5cnJ3SGhmU0Y3SnVNUGdr?oc=5","country":"ES","country_name":"Spain","language":"es","published_at":"2026-10-06T09:10:18-06:00"}],"source_url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbUZpUWVaUjBwYTM0cWhJVzB0aDFwc25iNHpmRm43MFV6bjBsekpKRGdVaVMzc0p5UkEzMXlyRmRPU1YzNkNtS1pMc2V6YXRIbHNMZlB0Z3BHX2JWM1U2RnNVRXBUU3RHWVFsU1U4VzZNdkVLSXp3Nml2bUhzbHhJTVN1T09rNVF2anl4VXBpRnVrWGNzN0VMQ28yYW1VUy1BOTF0ejdxeVM5cnJ3SGhmU0Y3SnVNUGdr?oc=5","publishers":[{"name":"Gaceta Médica","country":"ES","country_name":"Spain"}],"countries":["ES"]},"generated_at":"2026-11-13T18:53:53-06:00"}